Neuroscientific Biopharmaceuticals Ltd (NSB) — Cash Flow Reinvestment Rate

Latest as of June 2024: 0.00x

Neuroscientific Biopharmaceuticals Ltd (NSB) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting AU$1.82K (capex AU$1.82K ) from operating cash flow of AU$1.62 Million. Explore Neuroscientific Biopharmaceuticals Ltd (NSB) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

AU$1.82K

Capex + Investments

Operating Cash Flow

AU$1.62 Million

AUD

Capital Expenditures

AU$1.82K

AUD

Neuroscientific Biopharmaceuticals Ltd Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Neuroscientific Biopharmaceuticals Ltd across 1 annual periods. Also explore NSB asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Year-by-year capital reinvestment analysis for Neuroscientific Biopharmaceuticals Ltd. For live market cap and broader valuation context, see Neuroscientific Biopharmaceuticals Ltd (NSB) total market value.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2024	0.08x	AU$3.63K	AU$44.25K	AU$1.81K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow